Bryce Point Capital’s ResMed RMD Stock Holding History

Bryce Point Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,684	Closed	-$612K	–	250
2025 Q1	$612K	Sell	2,684 -5,270	-66%	-$1.23M	0.46%	148
2024 Q4	$1.82M	Buy	+7,954	New	+$1.92M	0.53%	23

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bryce Point Capital's RMD Position: Q2 2025 in Review

Bryce Point Capital sold out of ResMed (RMD) in Q2 2025, closing a stake of 2,684 shares — an estimated $612K sold.

Bryce Point Capital first reported a position in RMD in Q4 2024 and held it in 2 quarters. The position peaked at $1.82M in Q4 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Bryce Point Capital reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Bryce Point Capital sold 2,684 ResMed shares in Q2 2025, an estimated $612K.
Bryce Point Capital first reported a position in ResMed in Q4 2024 and held it in 2 quarters.
Bryce Point Capital's ResMed position peaked at $1.82M in Q4 2024.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Bryce Point Capital's 13F filing for Q2 2025, filed 5 Aug 2025.